Unknown

Dataset Information

0

Aromatase Inhibitor Therapy Is Associated with Distinct Plasma Lipidomic Profiles in Postmenopausal Breast Cancer Patients

ABSTRACT:

SUBMITTER: Arsic A 

PROVIDER: S-EPMC12940922 | biostudies-literature | 2026 Feb

REPOSITORIES: biostudies-literature

Json Xml

Similar Datasets

Unknown Challenges of measuring accurate estradiol levels in aromatase inhibitor-treated postmenopausal breast cancer patients on vaginal estrogen therapy.
| S-EPMC5684855 | biostudies-literature
Unknown Predicting the Benefit of Adjuvant Aromatase Inhibitor Therapy in Postmenopausal Breast Cancer Patients with Phosphorylated S6K1 Expression Status.
| S-EPMC7043945 | biostudies-literature
Unknown Sleep disturbances and restless legs syndrome in postmenopausal women with early breast cancer given adjuvant aromatase inhibitor therapy.
| S-EPMC9593725 | biostudies-literature
Unknown Molecular profiling of aromatase inhibitor sensitive and resistant ER+HER2- postmenopausal breast cancers.
| S-EPMC10328947 | biostudies-literature
Unknown Changes in LDL-cholesterol levels following aromatase inhibitor treatment in early postmenopausal breast cancer.
| S-EPMC12374885 | biostudies-literature
Unknown Association of Fat Body Mass With Vertebral Fractures in Postmenopausal Women With Early Breast Cancer Undergoing Adjuvant Aromatase Inhibitor Therapy.
| S-EPMC6777242 | biostudies-literature
Unknown Profiles of miRNAs matched to biology in aromatase inhibitor resistant breast cancer.
| S-EPMC5342075 | biostudies-literature
Unknown The Risk of Cardiovascular Disease following Aromatase Inhibitor Therapy for Breast Cancer in Postmenopausal Women: A Systematic Review and Meta-Analysis.
| S-EPMC12259065 | biostudies-literature
Unknown Obesity, adipokines, and C-peptide are associated with distinct plasma phospholipid profiles in adult males, an untargeted lipidomic approach.
| S-EPMC5524758 | biostudies-literature
Unknown Genomic alterations are associated with response to aromatase inhibitor therapy for ER-positive postmenopausal ductal carcinoma in situ: (CALGB 40903, Alliance).
| S-EPMC11843815 | biostudies-literature